# A Clinical Trial to Compare the Efficacy and Safety of a Combination Therapy of Ezetimibe and Rosuvastatin Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients (I-ROSETTE Study)

> **NCT02749994** · PHASE3 · COMPLETED · sponsor: **IlDong Pharmaceutical Co Ltd** · enrollment: 396 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** Rosuvastatin
- **DRUG:** Ezetimibe

## Key facts

- **NCT ID:** NCT02749994
- **Lead sponsor:** IlDong Pharmaceutical Co Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2017-02
- **Final completion:** 2017-02
- **Target enrollment:** 396 (ACTUAL)
- **Last updated:** 2018-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02749994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02749994, "A Clinical Trial to Compare the Efficacy and Safety of a Combination Therapy of Ezetimibe and Rosuvastatin Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients (I-ROSETTE Study)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02749994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*